HIV protease inhibitors, compositions containing the same,...

Details HIV protease inhibitors, compositions containing the same,... HIV protease inhibitors, compositions containing the same,...

2005-10-11

2005-10-11

Stockton, Laura L. (Department: 1626)

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

Reexamination Certificate

active

06953858

ABSTRACT:
Compounds of the formula:where the formula variables are as defined herein, are disclosed that advantageously inhibit or block the biological activity of the HIV protease. These compounds, as well as pharmaceutical compositions containing these compounds, are useful for treating patients or hosts infected with the HIV virus. Intermediates and synthetic methods for preparing such compounds are also described.

REFERENCES:
patent: 5629406 (1997-05-01), Higashida et al.
patent: 5644028 (1997-07-01), Mimoto et al.
patent: 5932550 (1999-08-01), Kato et al.
patent: 5962640 (1999-10-01), Kato et al.
patent: 6222043 (2001-04-01), Kato et al.
patent: 6313094 (2001-11-01), Mimoto et al.
patent: 6329502 (2001-12-01), Mimoto et al.
patent: 2002/0049165 (2002-04-01), Mimoto et al.
patent: 705193 (1997-02-01), None
patent: 2179935 (1996-06-01), None
patent: 0490667 (1992-06-01), None
patent: 0498680 (1992-08-01), None
patent: 0574135 (1993-12-01), None
patent: 0706794 (1996-04-01), None
patent: 0751145 (1996-06-01), None
patent: 8259532 (1996-10-01), None
patent: 10-87489 (1998-04-01), None
patent: 10101654 (1998-04-01), None
patent: 2003119137 (2003-04-01), None
patent: WO93/13066 (1993-07-01), None
patent: WO 93/13066 (1993-07-01), None
patent: WO 95/09843 (1995-04-01), None
patent: WO 98/46582 (1998-10-01), None
patent: WO 00/48466 (2000-08-01), None
patent: WO 02/100844 (2002-12-01), None
patent: WO 02/100845 (2002-12-01), None
patent: WO 03/035076 (2003-05-01), None
patent: WO 03/035650 (2003-05-01), None
patent: WO 03/047564 (2003-06-01), None
patent: WO 03/049690 (2003-06-01), None
patent: WO 03/062204 (2003-07-01), None
patent: WO 03/062238 (2003-07-01), None
Carlsen et al.. “Thermolysis of N-Allylic 1,2,4-Triazoles”Institute of Organic Chemistry34:797-805 (1997).
Demange et al., “Practical Synthesis of Boe and Fmoc Protected 4-Fluoro and 4-Difluoroprolines from Trans-4-Hydrozyproline,”Tetrahedron Letters39:1169-1172 (1998).
Harada et al., “Synthesis and Resolution of -N-I1-methyl-4(3-methylbenzyl)hexahydro-1H-1,14-dizepin-6-yl/]-1/H-indazole-3-Carboxamide By Preferential Crystallization,”Tetrahedron Asymmetry8(14):2367-2374 (1997).
Holzgrabe, U., “Cer(IV)sulfat-Oxidationen: Intramolekulare Cyclisierung von N-Benzyl-β-Aminoketonen zu 4-Benzoyl-1,2,3,4-tetrahydro-isochinolinen,”Arch. Pharm.320:647-654 (1987).
Karanewsky et al.. “Phosphinyloxy)acyl Amino Acid Inhibitors Of Angiotensin Converting Enzyme,”J. Med. Chem.33:1459-1469 (1990).
Ludeman et al. “Synthesis and Antitumor Activity of Cyclophosphamide Analogs. I. Benzo Annulated Cyclophosphamide and Related Systems,”Journal of Medicinal Chemistry18(12):1251 (1975).
Matayoshi et al.. “Novel Fluorogenic Substrates For Assaying Retroviral Proteases By Resonance Energy Transfer,”Science247:954-958 (1990).
Mimoto et al., “Structure-Activity Relationship of Small-Sized HIV Protease Inhibitors Containing Allophenylnorstatine,”J. Med. Chem.42:1789-1802 (1999).
O'Brien et al., “Inhibitors of Acyl-CoA:Choloesterol O-Acyl Transferase (ACAT) as Hypocholesterolemic Agents. Incorporation of Amide or Amine Functionalities into a Series of Disubstituted Ureas And Carbamates. Effects on ACAT Inhibition In Vitro and Efficacy In Vivo,”J. Med. Chem.37:1810-1822 (1994).
Pauwels et al.. “Rapid and Automated Tetrazolium-Based Colorimetric Assay For The Detection Of Anti-HIV Compounds,”Journal of Virological Methods20:309-321 (1988).
Weislow et al.. “New Soluble-Formazan Assay For HIV-1 Cytopathic Effects: Application To High-Flux For AIDS-Antiviral Activity,”Journal of the National Cancer Institute81(8):577-586 (1989).
Wipf et al., “SN2′-Reactions of Peptide Aziridines. A Cuprate-Based Approach to (E)-Alkene Isosteres”J. Org. Chem.59:4875-4886 (1994).
Yoshimura et al., “JE-2147: A Dipeptide Protease Inhibitor (PI) That Potently Inhibits Multi-PI-Resistant HIV-1,”Proc. Natl. Acad. Sci. USA96:8675-8680 (Jul. 1999).
Yoshiaki, Patent Abstracts of Japan, Publication No. 10182601, 1998, No. 12.
Sheha et al., Euro J. Med. Chem., vol. 35 (10), 2000, pp. 887-894.
Kitzaki et al., Chem & Pharm. Bulletin, Pharm. Soc. of Japan, vol. 42(12), 1994, pp. 2636-2640.
Slee, J.A.C.S., vol. 117(48), 1995, pp. 11867-11878.
Komai et al., Biorg. Med. Chem., vol. 4 (8), 1996, pp. 1356-1377.
Kiso et al., Arch. Pharm., Pharm. Med. Chem., vol. 331, 1998, pp. 87-89.
Matsumoto et al., Biorg. Med. Chem., vol. 9(2), 2001, pp. 417-430.
Tam et al., J. Med. Chem., vol. 35, No. 7, 1992, pp. 1318-1320.
Bell et al., J. Med. Chem. 41:2146-2163 (1998).
Bobbitt et al., J. Org. Chem. 25:560 (1960).
Charlesworth et al., Can. J. Chem. 41:1071-1077 (1963).
Dondoni et al., J. Org. Chem. 60:4749-4754 (1995).
Fujiwara et al., Can. J. Chem. 48:1346-1349 (1970).
Huang et al., Synthetic Communications 28 (7): 1197-1200 (1998).
Hursthouse et al., J. Chem. Soc. 1:2419-2425 (1995).
Miller et al., J. Org. Chem 24:560-561 (1958).
Nagasawa et al., J. Med. Chem. 30:1373 (1991).
Nussbaumer et al., J. Med. Chem. 34:65-73 (1991).
Onda et al., Chem. Pharm. Bull. 19 (10): 2013-2019 (1971).
Petropoulos et al., Antimicrob Agents Chemother 44(4): 920-928 (2000).
Van-Duc Le, Bioorg. Med. Chem. vol. 9, 2001, pp. 1185-1195.
Mimoto et al., Chem. & Pharm. Soc. Japan 48(9), 2000, pp. 1310-1326.
Sodergren, J. Am. Chem. Soc. 122(28),2000, pp. 6610-6618.
Falorni et al., Tetrahedron; Asymmetry, vol. 6 (1), 1995, pp. 287-294.
Andrés, “Stereoselective Cyanation of Chiral α-Amino Aldehydes By Reaction With Nagata's Reagent: A Route To Enantiopure β-Amino-α-Hydroxy Acids,”Tetrahedron Asymm.,2001, pp. 347-353, vol. 12.
Blanco, M. et al., “Enantiospecific And Stereoselective Synthesis Of Polyhydroxylated Pyrrolidines And Indolizidnes From Trans-4-Hydroxy-L-Proline,”J. Org. Chem.,1996, pp. 4748-4755, vol. 61.
Humphrey, J. et al., “Chemical Synthesis Of Natural Product Peptides: Coupling Methods For The Incorporation Of Noncoded Amino Acids Into Peptides,”Chemical Reviews,1997, 2243-2266 vol. 97.
Ikunaka, et al., “A Concise Synthesis of (2S,3S)-BocAHPBA and ®-BocDMTA, Chiral Building Blocks for Peptide-Mimetic HIV Protease Inhibitors,”Tetrahedron Asymmetry,2002, vol. 13, 1201.
Jacques, et al., Enantiomers, Racemates, and Resolutions, 1981, John Wiley & Sons, New York, Table of Contents only.
Larock, et al., Comprehensive Organic Transformation, 1989, Chapter 9, New York, p. 273-280.
Sasai, H., et al., “Diastereoselective Catalytic Asymmetric Nitroaldol Reaction Utilizing Rare Earth-Li-(R)-BINOL Complex. A Highly Efficient Synthesis of Norstatine,”Tetrahedron Letters,1994, pp. 6123-6126, vol. 35, No. 33.
Sharma, R. et al., “Regioselective Enolization And Alkylation Of 4-Oxo-N-(9-Phenylfluoren-9-yl)Proline: Synthesis Of Enantiopure Proline-Valine And Hydroxyproline-Valine Chimeras,”J. Org. Chem.,1996, pp. 202-209, vol. 61.
Sustmann, et al., Comprehensive Organic Synthesis, 1991, vol. 6, 301-321, Trost.
Patrick, et al., “Protease Inhibitors as Antiviral Agents”, Clinical Microbio. Reviews, Oct. 1998, pp. 614-627.

Affiliated with

Also associated with

Rating

HIV protease inhibitors, compositions containing the same,... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with HIV protease inhibitors, compositions containing the same,..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and HIV protease inhibitors, compositions containing the same,... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3451416